Intermittent Versus Continuous Erlotinib With Concomitant Modified XELOX (q3W) in First-Line Treatment of Metastatic Colorectal Cancer: Correlation With Serum Amphiregulin and Tran... von MA, Brigette B. Y, CHAN, Stephen L, TO, Ka F, KING, Ann D, AHUJA, Anil, CHAN, Anthony T. C, HO, Wing M, LAU, Wilson, MO, Frankie, HUI, Edwin P, CHAN, Charles, POON, Annette, DATTATRAY, Rasalkar D, WONG, S. C. Cesar

Volltext

Intermittent versus continuous erlotinib with concomitant modified “XELOX” (q3W) in first‐line treatment of metastatic colorectal cancer von Ma, Brigette B. Y., Chan, Stephen L., Ho, Wing M., Lau, Wilson, Mo, Frankie, Hui, Edwin P., Chan, Charles, Poon, Annette, Dattatray, Rasalkar D., Wong, S. C. Cesar, To, Ka F., King, Ann D., Ahuja, Anil, Chan, Anthony T. C.

Volltext